Literature DB >> 24318838

Acetylcholinesterase protein level is preserved in the Alzheimer's brain.

María-Letizia Campanari1, María-Salud García-Ayllón, Lidia Blazquez-Llorca, Wilson K W Luk, Karl Tsim, Javier Sáez-Valero.   

Abstract

Acetylcholinesterase (AChE) is a key enzyme in the cholinergic nervous system and is one of the most studied proteins in the field of Alzheimer's disease (AD). Moreover, alternative functions of AChE unrelated with the hydrolysis of acetylcholine are suspected. Until now, the majority of investigations on AChE in AD pathology have been focused on the determination of its enzymatic activity level, which is depleted in the AD brain. Despite this overall decrease, AChE activity increases at the vicinity of the two hallmarks of AD, the amyloid plaques and the neurofibrillary tangles (NFT). In fact, AChE may directly interact with Aβ in a manner that increases the deposition of Aβ to form plaques. In the context of protein-protein interactions, we have recently reported that AChE can interact with presenilin-1, the catalytic component of γ-secretase, influencing its expression level and also its activity. However, the alteration of AChE protein in the AD brain has not been determined. Here, we demonstrated by Western blotting and immunohistochemistry that a prominent pool of enzymatically inactive AChE protein existed in the AD brain. The potential significance of these unexpected levels of inactive AChE protein in the AD brain was discussed, especially in the context of protein-protein interactions with β-amyloid and presenilin-1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24318838     DOI: 10.1007/s12031-013-0183-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  86 in total

1.  Evaluation and quality control of a monoclonal antibody based enzyme antigen immunoassay of acetylcholinesterase in amniotic fluid.

Authors:  A G Rasmussen; J Arends; S O Larsen
Journal:  Scand J Clin Lab Invest       Date:  1989-10       Impact factor: 1.713

2.  Biogenesis of acetylcholinesterase molecular forms in muscle. Evidence for a rapidly turning over, catalytically inactive precursor pool.

Authors:  R L Rotundo
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

3.  Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  J Sáez-Valero; G Sberna; C A McLean; D H Small
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

5.  Necropsy evidence of central cholinergic deficits in senile dementia.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

6.  Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.

Authors:  María-Salud García-Ayllón; María-Ximena Silveyra; Niels Andreasen; Stephen Brimijoin; Kaj Blennow; Javier Sáez-Valero
Journal:  J Neurochem       Date:  2007-02-26       Impact factor: 5.372

7.  Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

Authors:  M Iyo; H Namba; K Fukushi; H Shinotoh; S Nagatsuka; T Suhara; Y Sudo; K Suzuki; T Irie
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

8.  Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.

Authors:  C I Wright; C Geula; M M Mesulam
Journal:  Ann Neurol       Date:  1993-09       Impact factor: 10.422

9.  Two-site immunoassay for acetylcholinesterase in brain, nerve, and muscle.

Authors:  S Brimijoin; P Hammond; Z Rakonczay
Journal:  J Neurochem       Date:  1987-08       Impact factor: 5.372

10.  Readthrough acetylcholinesterase is increased in human liver cirrhosis.

Authors:  María-Salud García-Ayllón; Cristina Millán; Carol Serra-Basante; Ramón Bataller; Javier Sáez-Valero
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

View more
  8 in total

1.  Journal of molecular neuroscience: impacting our brains.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2014-11       Impact factor: 3.444

2.  Rescue and Stabilization of Acetylcholinesterase in Skeletal Muscle by N-terminal Peptides Derived from the Noncatalytic Subunits.

Authors:  Carlos A Ruiz; Susana G Rossi; Richard L Rotundo
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

Review 3.  Biogenesis, assembly and trafficking of acetylcholinesterase.

Authors:  Richard L Rotundo
Journal:  J Neurochem       Date:  2017-03-21       Impact factor: 5.372

4.  Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer's disease.

Authors:  Maliheh Soodi; Soodabeh Saeidnia; Mohammad Sharifzadeh; Homa Hajimehdipoor; Abolfazl Dashti; Mohammad Reza Sepand; Shahla Moradi
Journal:  Metab Brain Dis       Date:  2015-12-07       Impact factor: 3.584

5.  Hydrogen peroxide modifies both activity and isoforms of acetylcholinesterase in human neuroblastoma SH-SY5Y cells.

Authors:  Alba Garcimartín; M Elvira López-Oliva; M Pilar González; Francisco J Sánchez-Muniz; Juana Benedí
Journal:  Redox Biol       Date:  2017-04-04       Impact factor: 11.799

6.  Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex.

Authors:  Xiang-Peng Kong; Etta Y L Liu; Zhi-Cong Chen; Miranda Li Xu; Anna X D Yu; Qi-Yun Wu; Ying-Jie Xia; Ran Duan; Tina T X Dong; Karl W K Tsim
Journal:  Molecules       Date:  2019-12-13       Impact factor: 4.411

7.  Proceedings of workshop: "Neuroglycoproteins in health and disease", INNOGLY cost action.

Authors:  Esther Llop; Ana Ardá; Elsa Zacco; Roisin O'Flaherty; María-Salud García-Ayllón; Massimo Aureli; Moran Frenkel-Pinter; Celso A Reis; Ole K Greiner-Tollersrud; Inmaculada Cuchillo-Ibáñez
Journal:  Glycoconj J       Date:  2022-08-24       Impact factor: 3.009

8.  Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.

Authors:  Maria-Letizia Campanari; Francisco Navarrete; Stephen D Ginsberg; Jorge Manzanares; Javier Sáez-Valero; María-Salud García-Ayllón
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.